How Long Is Cytomegalovirus (CMV) Contagious?

Cytomegalovirus does not have a single contagious window the way a cold or the flu does. During a first infection, a person typically sheds virus in saliva, urine, and other body fluids for weeks to months. But because CMV establishes a lifelong presence in the body, episodes of viral shedding can recur unpredictably for years, even in people who feel perfectly healthy. The practical answer depends heavily on whether you are asking about an adult’s first infection, a baby born with congenital CMV, or someone whose immune system is suppressed.

Shedding During a First Infection

When a healthy adult catches CMV for the first time, the illness often looks like a prolonged case of the flu. A case series of adults with confirmed primary CMV found that the average duration of illness was roughly four to five weeks, with symptoms like fatigue, night sweats, muscle aches, and headache.¹ Viral shedding, though, often outlasts the symptoms. Research on pregnant women with primary CMV infection found that shedding in saliva, urine, and vaginal secretions can persist for at least a year, and that it tapers as the immune system builds up both antibody and memory T-cell responses.² So even after you feel better, you can still be passing the virus to others through everyday contact with your saliva or urine for months.

That gap between feeling well and actually being done shedding virus is one of the reasons CMV spreads so efficiently. Most adults never realize they had CMV in the first place, and the virus continues circulating through body fluids long after any noticeable illness has resolved.

How Long Infected Children Shed the Virus

Babies born with congenital CMV are a particularly potent source of the virus, and they shed it for far longer than most adults do. At three months of age, one study found that every saliva and urine sample tested was positive for CMV.³ At 18 months, all urine samples were still positive, even though saliva positivity had dropped considerably.³ A larger study of nearly 200 children with congenital CMV tracked saliva shedding over time and found a median duration of 20 months. Shedding started at 100 percent at the time of diagnosis and gradually declined to under 10 percent by four years after enrollment.⁴ That duration was the same whether a child had symptoms at birth or not, and whether or not they developed hearing loss.⁴

The practical takeaway is that a congenitally infected infant can be contagious for roughly two years on average, with some continuing to shed virus for even longer. A review of shedding studies reported that children with congenital CMV had a median shedding prevalence of about 80 percent, with a steep decline by age five.⁵ This is why toddlers and preschool-age children, especially in group childcare, are considered the most common source of CMV exposure for adults.

Children who acquire CMV after birth rather than before it also shed virus at high rates. A study of healthy children at a community event found that about 11 percent of children tested positive for CMV in their saliva, with the highest prevalence at age three (over a quarter of kids tested) and the highest viral loads at age one.⁶ Young children drool, mouth toys, and share cups with abandon, so a child shedding CMV in their saliva is essentially broadcasting the virus to anyone who handles their things.

Intermittent Shedding in Healthy Adults

Here is where the question “how long is CMV contagious?” gets genuinely tricky. Once you have been infected, CMV never fully leaves your body. It hides inside certain immune cells in a dormant state, and it can periodically reactivate and produce infectious virus without causing any symptoms at all. This is not a rare edge case. A six-month study of healthy, seropositive college-aged women found that about 29 percent shed CMV in their saliva or urine at some point during the study period, with the average prevalence of active shedding at any single visit hovering around 5 percent.⁷ Most shedding episodes were brief and self-limited, but the longest lasted 43 days, and about 7 percent of participants shed virus for two weeks or more.⁷

This intermittent, symptom-free shedding is probably how most adult-to-adult CMV transmission occurs outside of the neonatal period. The person doing the shedding has no idea they are contagious, and the episodes are sporadic enough that routine screening would miss most of them. In effect, a previously infected person can be transiently contagious at unpredictable intervals for life.

Which Body Fluids Carry the Virus

Not all body fluids carry CMV equally, and understanding which ones matter can help you gauge where transmission risk is highest. A pilot study of healthy postpartum women found that breast milk was the dominant route of shedding: about 68 percent of breast milk samples tested positive for CMV. By contrast, only about 15 percent of vaginal swabs and 21 percent of oral swabs were positive, and the virus was not detected in any urine or blood samples from the same women.⁸ This finding is specific to postpartum women; in other populations, saliva and urine are the body fluids most commonly positive for CMV.

For mothers who are seropositive, breast milk transmission is actually quite common and usually benign in full-term infants. In premature infants, though, CMV acquired through breast milk can occasionally cause serious illness. This illustrates a broader principle: the same body fluid carrying the same viral load can pose vastly different risks depending on the person receiving it.

Blood is worth mentioning separately. CMV resides inside white blood cells rather than floating freely in plasma, which is why standard blood transfusions were historically a transmission route. Modern blood banks use leukocyte-reduction filters that remove white blood cells from donated blood, making transfusion-transmitted CMV rare in current practice.⁹

How Long CMV Survives Outside the Body

A question that naturally follows from “how long am I contagious” is whether the virus can linger on surfaces and objects. The answer is yes, for hours rather than days. One study found that CMV remained viable on metal and wood for up to one hour, on glass and plastic for up to three hours, and on rubber, cloth, and food items like crackers for up to six hours.¹⁰ Earlier work confirmed that CMV can survive several hours on non-absorbent surfaces and at least an hour on absorbent ones, and that common nursery disinfectants did not always fully eliminate it from surfaces.¹¹

These survival times matter in daycare and hospital settings, where shared toys, changing tables, and feeding equipment can act as bridges between one child’s saliva and another person’s hands. The virus is not rugged the way norovirus is, but it persists long enough that a toy mouthed by a shedding toddler could plausibly infect someone who picks it up 30 minutes later and then touches their own mouth or eyes.

Shedding in People with Weakened Immune Systems

The immune system is the main brake on CMV shedding. When that brake is weakened, viral replication can accelerate dramatically, and the contagious period stretches accordingly. In organ transplant recipients, the duration of detectable CMV in the blood depends heavily on the type and intensity of immunosuppressive drugs used. One study of kidney transplant patients found that the median duration of CMV detected in blood ranged from three weeks to seven weeks depending on the immunosuppressive regimen, with more aggressive suppression producing longer and higher-level viral replication.¹²

In people with advanced HIV or those undergoing chemotherapy, uncontrolled CMV replication can persist for months and cause severe disease affecting the eyes, gut, and lungs. The relationship between immune status and CMV control is direct: the weaker the immune response, the longer and more profusely the virus replicates, and the more contagious the person becomes.¹³ For immunocompromised patients receiving antiviral treatment, shedding typically continues until the immune system either recovers enough to contain the virus or the antivirals bring viral levels down.

Why CMV Is Contagious for Life

The reason CMV can be contagious intermittently forever, rather than just once, comes down to its ability to hide. After a primary infection, CMV tucks itself into myeloid cells, a type of immune cell, and enters a dormant phase where it produces almost no viral proteins. In this latent state, the virus is invisible to the immune system and not contagious. CMV infects up to 90 percent of the world’s population this way, sitting quietly for the remainder of a person’s life.¹⁴ Periodically, though, something triggers those dormant viral genes to switch back on. That could be stress, illness, pregnancy, or immune suppression from medications. When the virus reactivates, it begins replicating and shedding again in body fluids until the immune system shuts it back down.

Mother-to-child transmission underscores this point. CMV can be transmitted to a fetus regardless of whether the mother caught the virus recently or years earlier.¹⁵ In one study, half of the mothers of infants who acquired CMV postnatally developed reactivated CMV infection themselves, shedding virus in their saliva for a median of about 18 weeks after their infant became infected.¹⁶ In other words, close contact with a shedding child can trigger a mother’s dormant virus to wake up, creating a cycle of transmission within a household.

The Pregnancy Transmission Window

For pregnant women, the critical concern is not how long they are contagious to others, but when during pregnancy exposure to CMV is most dangerous for the baby. Primary maternal infection carries roughly a 30 to 40 percent risk of transmitting the virus to the fetus.¹⁷ Transmission can occur at any point in pregnancy, but the consequences differ by timing. One study found that infections in the first half of pregnancy were more likely to produce symptomatic illness and lasting disability in the infant, even though the overall rate of transmission was actually somewhat higher later in pregnancy (around 58 percent after 20 weeks versus 30 percent between weeks 6 and 20).¹⁸ Periconceptional infections, occurring right around the time of conception, also carried a substantial transmission risk of about 45 percent in that same analysis.¹⁸

This is why the months-long shedding duration of young children is so relevant to pregnant women. If you are pregnant and caring for a toddler who is shedding CMV, your exposure is not a single event. It is repeated, daily, and can last as long as the child continues to shed, which as discussed above averages around 20 months for congenitally infected children and likely several months for children who acquired CMV after birth.

Reducing Your Exposure Through Hygiene

Because there is no widely available CMV vaccine yet, prevention rests almost entirely on behavior. The American College of Obstetricians and Gynecologists recommends that physicians counsel pregnant women about avoiding CMV through careful hygiene, since saliva and urine from young children are the major sources of infection.¹⁹ A systematic review of hygiene interventions found that education about hand-washing and avoiding contact with children’s saliva consistently reduced the rate at which pregnant women acquired new CMV infections.²⁰

The specific measures are unglamorous but effective:

Hand-washing: After changing diapers, wiping a child’s nose, or handling toys that have been in a child’s mouth.
Avoiding mouth contact: Not sharing utensils, cups, or toothbrushes with young children, and kissing on the forehead or cheek rather than the lips.
Surface cleaning: Wiping down high-touch surfaces and toys, especially in childcare settings, since CMV can survive on surfaces for hours.

These precautions are most strongly recommended for women who are pregnant or planning to become pregnant, but they apply to anyone who wants to reduce their CMV exposure, particularly people who are immunosuppressed.

Occupational Exposure for Childcare and Healthcare Workers

Given how long children shed CMV, you might expect daycare workers and pediatric nurses to have dramatically higher infection rates. The picture is a bit more nuanced. A systematic review and meta-analysis found that childcare workers had a pooled CMV seroprevalence of about 59 percent, compared to roughly 50 percent in healthcare workers. The annual rate of new infections was higher in childcare workers at about 7 per 100 person-years versus about 3 per 100 person-years for healthcare workers.²¹ The odds of being seropositive were about 1.6 times higher for childcare workers compared to the general population, but for healthcare workers the difference was not statistically significant.²¹

An older but influential study of pediatric healthcare workers found a similar conclusion: despite frequently caring for infants who were actively shedding CMV, nurses and other hospital staff did not face a significantly greater risk of acquiring the virus than young women in the general community.²² The explanation probably lies in the fact that standard infection-control precautions, including gloves, hand-washing, and proper handling of body fluids, are already part of the healthcare routine and go a long way toward preventing transmission. The real added risk seems to concentrate among childcare workers, where gloves are rarely worn and contact with children’s saliva is constant and informal.

Antiviral Treatment and Shedding Duration

Antiviral drugs like ganciclovir and valganciclovir are used primarily in two situations: treating severe CMV disease in immunocompromised patients, and treating congenital CMV in newborns. For infants born with symptomatic congenital CMV, current guidelines recommend a six-month course of valganciclovir, with intravenous ganciclovir reserved for the initial two to six weeks in life-threatening cases.²³ The goal of treatment is to reduce viral replication and protect hearing and neurodevelopment, not primarily to shorten contagiousness, though lower viral loads do translate into less shedding.

In transplant recipients, antiviral prophylaxis or preemptive therapy suppresses CMV replication and reduces the duration of detectable virus in the blood. However, once antivirals are stopped, reactivation can occur again, especially if immune suppression is ongoing. There is no antiviral regimen that cures CMV or eliminates latent virus. Treatment shortens individual episodes of active shedding but does not prevent future ones, so the overall contagious timeline remains open-ended.

For healthy adults experiencing their first CMV infection, antivirals are almost never prescribed because the illness is self-limited and the drugs carry significant side effects, including bone marrow suppression. In that setting, the contagious period simply runs its natural course, usually several weeks to months of active shedding before the immune system brings the virus under control and forces it into dormancy.

1
PubMed Central. Primary cytomegalovirus infection in immunocompetent adults in the United States – A case series
2
PubMed. Human cytomegalovirus (HCMV) long-term shedding and HCMV-specific immune response in pregnant women with primary HCMV infection
3
PubMed. Viral shedding, and distribution of cytomegalovirus glycoprotein H (UL75), glycoprotein B (UL55), and glycoprotein N (UL73) genotypes in congenital cytomegalovirus infection
4
PubMed. Cytomegalovirus Saliva Shedding Kinetics in Children with Congenital CMV Infection
5
PubMed Central. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection
6
PubMed Central. High Prevalence of Asymptomatic CMV Shedding in Healthy Children Attending the Minnesota State Fair
7
The Journal of Infectious Diseases. Cytomegalovirus Shedding in Healthy Seropositive Female College Students: A 6-Month Longitudinal Study
8
PubMed Central. Cytomegalovirus shedding from breastmilk and mucosal sites in healthy post-partum women: a pilot study
9
PubMed Central. Risk of cytomegalovirus transmission by blood products after solid organ transplantation
10
PubMed Central. Cytomegalovirus survival on common environmental surfaces: opportunities for viral transmission
11
Pediatric Research. SURVIVAL OF CYTOMEGALOVIRUS (CMV) ON ENVIRONMENTAL SURFACES
12
PubMed. Effects of changing immunosuppressive regimen on the incidence, duration, and viral load of cytomegalovirus infection in renal transplantation: a single center report
13
PubMed Central. The immune response to human CMV
14
American Journal of Transplantation. Literature Watch Dissecting CMV latency and reactivation: BETing on the epigenetic regulators
15
PubMed Central. Mother-to-Child Transmission of Cytomegalovirus and Prevention of Congenital Infection
16
PubMed Central. Non-Primary Maternal CMV Infection Following Viral Shedding in Infants
17
JAMA. Primary Cytomegalovirus Infection in Pregnancy: Incidence, Transmission to Fetus, and Clinical Outcome
18
PubMed. Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease
19
PubMed Central. Washing our hands of the congenital cytomegalovirus disease epidemic
20
PubMed. Hygiene interventions for prevention of cytomegalovirus infection among childbearing women: systematic review
21
PubMed Central. Prevalence, incidence, and risk factors associated with cytomegalovirus infection in healthcare and childcare worker: a systematic review and meta-analysis
22
PubMed. Occupational risk for primary cytomegalovirus infection among pediatric health-care workers
23
PubMed Central. Treatment of congenital cytomegalovirus infection